PharMerica Corporation (NYSE:PMC) operates institutional pharmacies in 44 states. PharMerica’s customers are institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals and other long-term care providers. PharMerica Corporation also provides pharmacy management services to long-term care hospitals. PharMerica Corporation is a leading institutional pharmacy services company servicing healthcare facilities in the United States.



PharMerica Corporation yesterday announced that its Board of Directors, after careful consideration with its independent financial and outside legal advisors, voted unanimously to reject the unsolicited tender offer made by Omnicare to acquire PharMerica for $15.00 per share in cash. The Board determined that the offer undervalues PharMerica and is not in the best interests of PharMerica's stockholders.

In addition to undervaluing PharMerica and its future prospects, the Board believes the offer is illusory because it is subject to significant regulatory and other uncertainty. The Board unanimously recommends that PharMerica stockholders reject Omnicare's offer and not tender their shares to Omnicare. The Board noted that the value offered by Omnicare is unchanged from the unsolicited proposal it first made privately on July 19, 2011 and subsequently made public on August 23, 2011.

For more information about PharMerica, please visit www.pharmerica.com



*****************************
Enzo Biochem Inc. (ENZ)

In the field of health biotechnologies products are created and improved to be used as vaccines, drugs, diagnostic and testing equipment, as well as medical devices. Vaccines utilize weak or inactive forms of viruses in order to prepare the immune system for an infection. Agents used in gene and stem cell therapies are biologically engineered medical innovations. New diagnostics equipment for HIV and diabetes as well as advanced prosthesis is also the creations of biotechnology in the medical field.

Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.

Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.

The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D'Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.

Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary's operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo's presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.

For more information please visit: www.enzo.com

************************

Cleantech Transit, Inc. (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net).

Biomass is made up of carbon, hydrogen, and oxygen. There are commonly trace elements such as nitrogen, heavy metals, and alkali in the biomass as well. Biomass is energy that is created from essentially only five sources. Alcohol fuels, garbage, landfill gas, waste and wood. Wood is a major energy supplier. Black liquor is a waste product of wood, coming from the pulp of paper production. Waste energy is produced from manufacturing waste, solid waste, and landfill gases. This constitutes the second largest source of biomass.

Ethanol is created mostly from sugarcane and corn. It is considered an alcohol based fuel and is used as a fuel for motor vehicles as well as a fuel additive to enhance performance. Rotting garbage and human waste produces landfill gas, or methane gas. Ethanol gas can be used for transportation fuel, and biodiesel, which is produced from used cooking oils and animal fat.

Sugar cane and recycled wood are used to create energy at the largest biomass power plant in the United States. This single facility produces enough energy to not only power its own operations, but also to supply renewable energy to almost 60,000 houses and reduce oil dependence by over a million barrels each year.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.







For more read: pennyotcstock.com/?p=17220